South Sudan is amongst the highly endemic countries for onchocerciasis in Africa, with the disease endemic in around half (49%) the country (1). The most highly endemic foci of onchocerciasis in South Sudan are in Western Equatoria, and Northern and Western Bahr el Ghazal regions. However, in 2006 only 26% of the eligible population received ivermectin in five community directed treatment with ivermectin (CDTi) targeted areas (2) (Fig. 1).

Read More...

Leave a comment.

Your email address will not be published. Required fields are marked*

Andoird App
Loading...